People In Health Care
Professor Rosemary Harrup, Tasmania
Rosemary Harrup trained in Victoria and Tasmania in Medical Oncology and Clinical Haematology, completing a dual Fellowship in 2001. She is the current Director of Cancer and Blood Services at the Royal Hobart Hospital (RHH), a role she has held since 2009.
External to the RHH she is a member of the board of the Cancer Council of Tasmania, the Tasmanian Cancer Registry Advisory Group and the RHH Research Foundation Scientific and Advisory Committee.
Rosemary is currently Deputy Chair of the Cooperative Trials Group for Neuro oncology (COGNO), a member of the Australian Brain Cancer Mission Steering Committee and the Australian Cancer Plan Tasmanian jurisdictional representative. She has a strong interest in clinical research, particularly in the areas of Clinical Trials in Brain Cancer, Malignant Haematology and Late Effects and is an active mentor for early career researchers.
Australian Health Journal spoke to Rosemary about her journey in medicine and specifically her work in Clinical Trials in Brain Cancer and the value she placed on her senior clinicians as mentors and how she now mentors others.
You Might also like
-
Medical colleges reform to address accessibility, affordability and rural challenges
Australia’s specialist medical colleges are introducing significant changes to their training selection processes to tackle the ongoing shortage of specialist doctors in rural and remote areas. The Council of Presidents of Medical Colleges (CPMC), in collaboration with the National Rural Health Commissioner, has unveiled new guidelines that prioritise candidates with rural backgrounds and experience during trainee selection.
-
Message from former Australian Health Minister Hon Greg Hunt
The Honourable Greg Hunt served in the Australian Government as Minster for Health and Aged Care from 2017, previously as Industry, Innovation and Science Minister and before that the Environment Minister.
Elected as the Member for Flinders in 2001, Greg announced his retirement from politics late 2021 and in 2022, ahead of the Federal Election, having completed 20 years as a public servant.
Australian Health Journal recently caught up with Greg in a relaxed interview at his home in the Mornington Peninsula, Victoria to hear how a 9 month sabbatical has allowed him to focus on family, fitness and future. This has even included some “brutal spin cycle classes!”.
-
Awareness, diagnosis and treatment of Congenital Hypothyroidism
Australian Health Journal spoke to Associate Professor MIchelle Jack about congenital hypothyroidism and newborn screening and her concerns in the varying thresholds for across different states in Australia. Despite the existence of newborn screening programs since the 1970s, there is still controversy surrounding the appropriate screening levels. Congenital hypothyroidism, affecting about one in 3500 infants, can lead to severe intellectual and physical impairment if not diagnosed early. The condition is mainly caused by the thyroid gland’s failure to develop properly, resulting in insufficient thyroid hormone production.